Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats

British Journal of Pharmacology

Volumn 120, Issue 2, 1997, Pages 282-288

  Malhotra, Jatinder ^a   Gupta, Yogendra K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

2 chloroadenosine (2 CADO); 3,7 dimethyl 1 propargylxanthine (DMPX); 5' (N cyclopropyl) carboxamidoadenosine (CPCA); 8 cyclopentyl 1,3 dipropylxanthine (DPCPX); Adenosine; N6 cyclopentyladenosine (CPA); Pentylenetetrazole (PTZ); PTZ kindled seizures; Theophylline

Indexed keywords

2 CHLOROADENOSINE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N CYCLOPROPYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; PENTETRAZOLE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; HEART RATE; HYPOTENSION; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; SEIZURE;

ADENOSINE; ANIMALS; BLOOD PRESSURE; BODY TEMPERATURE; HEART RATE; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; SEIZURES; XANTHINES;

EID: 0031023948     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700869     Document Type: Article

References (41)

1. 1 receptors: intracellular analysis of the actions of adenosine agonists and antagonists in rat hippocampal neurons. Brain Res., 546, 69-78.
2. 1 adenosine receptors in different mouse brain areas after pentylenetetrazole induced seizures but not in epileptic mutant mouse 'tottering'. Brain Res., 534, 251-256.
3. 2a purine receptors regulate striatal acetylcholine release. J. Neurochem., 55, 31-38.
4. BRUNS, R.F., FERGUS, J.H., BADGER, E.W., BRISTOL, J.A., SANTAY, L.A., HARTMAN, J.D., HAYS, S.J. & HUANG, C.C. (1987). Binding of the A1 selective adenosine antagonist 8-cyclopentyl-1,3-dipropyl xanthine to rat brain membranes. Naunyn-Schmeideberg's Arch. Pharmacol., 335, 59-63.
5. 3H] NECA in rat striatial membranes. Mol. Pharmacol., 29, 331-346.
6. BURKE, S.P. & NADLER, J.V. (1988). Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: Effects of adenosine and baclofen. J. Neurochem., 51, 1541-1551.
7. CUTRUFO, C., BORTOT, L., GIACHETTI, A. & MANZINI, S. (1992). Differential effects of various xanthines on pentylenetetrazole induced seizures in rats: an EEG and behavioural study. Eur. J. Pharmacol., 222, 1-6.
8. DOLPHIN, A.C. & ARCHER, C.R. (1983). An adenosine agonist inhibits and a cyclic AMP analogue enhanced the release of glutamate but not GABA from slices of rat dentate gyrus. Neurosci. Lett., 43, 49-54.
9. DRAGUNOW, M. (1986). Endogenous anticonvulsant substances. Neurosci. Biobehave. Rev., 10, 229-244.
10. DRAGUNOW, M. & GODDARD, G.V. (1984). Adenosine modulation of amygdala kindling. Exp. Neurol., 84, 654-665.
11. DRAGUNOW, M., GODDARD, G.V. & LAVERTY, R. (1985). Is adenosine an endogenous anticonvulsant? Epilepsia, 26, 480-487.
12. DUNWIDDIE, T.V. (1980). Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia, 21, 541-548.
13. DUNWIDDIE, T.V. & WORTH, T. (1982). Sedative and anticonvulsant actions of adenosine analogs in mouse and rat. J. Pharmacol. Exp. Ther., 220, 70-76.
14. DURING, M.J. & SPENCER, D.D. (1992). Adenosine: A potential mediator of seizure arrest and post-ictal refractoriness. Ann. Neurol., 32, 618-624.
15. 1 receptor activation mediates suppression of (-)-bicuculline methiodide-induced seizures in rat prepiriform cortex. J. Pharmacol. Exp. Ther., 251, 1229-1236.
16. HORNFELDT, C.S. & LARSON, A.A. (1994). Adenosine receptors are not involved in theophylline-induced seizures. Clin. Toxicol., 32, 257-265.
17. JONZON, B., BERGQUIST, A., LI, Y.O. & FREDHOLM, B.B. (1986). Effects of adenosine and two stable adenosine analogues on blood pressure, heart rate and colonic temperature in the rat. Acta Physiol. Scand., 126, 491-498.
18. KRYZHANOVSKII, G.N., KARPOVA, M.N. & PANKOV, O.I. (1990). Effects of organic calcium antagonists and magnesium on the development of corazol kindling. Biull. Eksp. Biol. Med., 110, 348-350.
19. LONDOS, C., COOPER, D.M.F. & WOLFF, J. (1980). Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. U.S.A., 77, 2552-2554.
20. MAITRE, M., CIESIELSKI, L., LEHMAN, A., KEMPF, E. & MANDEL, P. (1974). Protective effect of adenosine and nicotinamide against audiogenic seizures. Biochem. Pharmacol., 23, 2807-2816.
21. MALHOTRA, J., SETH, S.D., GUPTA, S.K. & GUPTA, Y.K. (1996). Adenosinergic mechanisms in anticonvulsant action of diazepam and sodium valproate. Env. Toxicol. Pharmacol., 1, 269-277.
22. MARANGOS, P,J., LOFTUS, T., WIESNER, J., LOWE, T., ROSSIE, E., BROWNE, C.E. & GRUBER, H.E. (1990). Adenosinergic modulation of homocysteine-induced seizures in mice. Epilepsia, 31, 239-246.
23. 1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels. J. Pharmacol. Exp. Ther., 260, 437-443.
24. MORAIDIS, I. & BINGMANN, D. (1994). Epileptogenic actions of xanthines in relation to their affinities for adenosine A1 receptors in CA3 neurons of hippocampal slices (guinea pig). Brain Res., 640, 140-145.
25. NAGAI, T., SUZUKI, Y., ARAI, H., IMAI, K., KODAKA, R., ITAGAKI, Y., TANAKA, J., ONO, J. & OKADA, S. (1993). Effects of pentylenetetrazole (PTZ) kindling on GABAergic system: A histochemical study by staining for GABA-transaminases (GABA-T). Jap. J. Psychiatr. Neurol., 47, 392-393.
26. OLSSON, R.A. & PEARSON, J.D (1990). Cardiovascular purinoceptors. Physiol. Rev., 70, 761-845.
27. 2 adenosine receptor agonist CGS 21680 enhances excitatory amino acid release from the ischemic rat cerebral cortex. Neurosci. Lett., 138, 169-172.
28. PELLEG, A. & PORTER, R.S. (1990). The pharmacology of adenosine. Pharmacotherapy, 10, 157-174.
29. PETERSEN, E.N. (1991). Selective protection by adenosine receptor agonists against DMCM-induced seizures. Eur. J. Pharmacol., 195, 261-265.
30. 2 receptor agonist CGS 21680 is a potent depressant of cerebral cortical neuronal activity. Brain Res., 509, 328-330.
31. PHILLIS, J.W. & WU, P.H. (1983). The role of adenosine in central neuromodulation. In Regulatory Function of Adenosine ed. Berne, R.M., Rall, T.V. & Rubio, R. pp. 419-437 The Hague: Martinus Nishoff.
32. PSARROPOULOU, C., MATSOKIS, N., ANGELATOU, F. & KOSTOPOULOUS, G. (1994). Pentylenetetrazole induced seizures decrease gamma-Aminobutyric acid-mediated recurrent inhibition and enhance adenosine-mediated depression. Epilepsia, 35, 12-19.
33. 3) adenosine receptor. Prog. Neurobiol., 26, 179-209.
34. SCHULTZ, V. & LOWENSTEIN, J.M. (1978). The purine nucleotide cycle: studies of ammonia production and interconversion of adenine and hypoxanthine nucleotides and nucleosides by rat brain in situ. J. Biol. Chem., 253, 1938-1943.
35. SCHWABE, U., UKENA, D. & LOHSE, M.J. (1985). Xanthine derivatives as antagonists at A1 and A2 receptors. Naunyn-Schmideberg's Arch. Pharmacol., 330, 212-221.
36. SOLLEVI, A., LAGERKRANSER, M., ANDREEN, M. & IRESTEDT, L. (1984). Relationship between arterial and venous adenosine levels and vasodilatation during ATP and adenosine - infusion in dogs, Acta Physiol. Scand., 120, 171-176.
37. VAN WYLEN, D.G.L., SCIOTTI, V.M. & WINN, H.R. (1991). Adenosine and Adenosine Nucleotides as Regulators of Cellular Function, p. 19. Boca Raton: CRC press.
38. 6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice. Eur. J. Pharmacol., 249, 265-270.
39. WILLIAM, M. (1990). Purine nucleosides and nucleotides as central nervous system modulators. Ann. New York Acad. Sci., 603, 93-107.
40. WINN, H.R., WELSH, J.E., RUBIO, R. & BERNE, R.M. (1980). Changes in brain adenosine during bicuculline-induced seizures in rats. Circ. Res., 47, 568-577.
41. ZHANG, G., FRANKLIN, P.H. & MURRAY, T.F. (1994). Activation of adenosine A1 receptor underlies anticonvulsant effect of CGS 21680. Eur. J. Pharmacol., 255, 239-243.